How Psychedelic Drug Stocks Took Off in 2020

After some early turbulence in 2020, psychedelic drug stocks have taken off.

Read more
Numinus Completes First Extraction of its Psilocybe Mushrooms

VANCOUVER, BC , Dec. 17, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.

Read more
Silicon Valley Bets Billions On Rise Of “Digital Therapeutics”

Numinus Completes First Extraction of its Psilocybe Mushrooms 2020-12-17 Stockhouse Staff VANCOUVER, BC , Dec. 17, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms…

Read more
Numinus Wellness : Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

Numinus acquires a Montreal-based provider of psychedelic-assisted psychotherapies.

Read more
MindMed Upsizes Previously Announced CAD $50m Bought Deal Public Offering

MindMed increases its latest bought-deal financing to CAD$80 million.

Read more
UK Approves Trials Testing DMT as Depression Treatment

The United Kingdom has approved trials by London-based Small Pharma for assessing the safety, and later efficacy, of N,N-dimethyltryptamine – or DMT – for depression, according to a Pharm Exec report. It is the world’s first clinical trial for studying DMT as a depression treatment.

Read more
Feds Announce $350K Grant To Develop Method To Distinguish Hemp And Marijuana

The Department of Justice is issuing a different federal agency a grant to help to develop a method of differentiating hemp and marijuana.

Read more
Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries.

Read more
Drip Series -TSI-DWR-E3

Dear %%First Name| reader%%, Something big is happening.  A small group of stocks have started moving, but that’s just the start. A $3 trillion tech disruption tidal wave could send them soaring many times over. And here’s how to get in on the ground floor.   New industry leaders are already off…

Read more
Drip Series -TSI-DWR-E4

Dear %%First Name|reader%%,  Forget about the latest iPhone announcement. This is bigger than that, way bigger. Business Insider estimates this could worth $3.3 TRILLION.   Apple is making some big moves that will have a far greater impact on the future of the world and your wealth.  You see, the world’s…

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )